FOXO4-DRI 10mg

FOXO4-DRI 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

FOXO4-DRI is a synthetic peptide research compound developed for advanced laboratory investigations involving peptide-protein interactions, molecular signalling and intracellular regulatory pathways. Its engineered molecular structure has attracted scientific interest within experimental peptide research, where investigators continue to explore complex protein-interaction mechanisms and cellular signalling systems under carefully controlled laboratory conditions. This preparation contains 10 mg of lyophilized FOXO4-DRI supplied in a sealed research vial. Independent analytical testing measured an assay content of 12.20 mg for this production batch. Chromatographic analysis confirmed 99.7 percent purity, while identity was independently evaluated through FTIR spectrum analysis, retention time confirmation and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result below 0.001 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its defined molecular identity, reproducible analytical profile and comprehensive third-party verification, FOXO4-DRI provides researchers with a well-characterised peptide material suitable for advanced molecular investigations and controlled in vitro laboratory studies.  

Peptide Overview

FOXO4-DRI is a synthetic peptide research compound commonly utilised in laboratory investigations involving peptide chemistry, protein interactions and intracellular molecular communication. The compound forms part of experimental peptide research focused on molecular interaction systems and complex intracellular signalling pathways. Researchers employ FOXO4-DRI in controlled experimental models designed to investigate peptide-protein interactions, molecular signalling pathways and biochemical regulatory mechanisms. Its defined molecular structure and reproducible analytical characteristics allow identity and quality parameters to be evaluated using complementary chromatographic, spectroscopic and mass spectrometric techniques. Today, FOXO4-DRI continues to form part of the expanding field of experimental peptide science involving molecular biology, peptide interactions and cellular research.  

Historical Background and Scientific Context

Advances in peptide engineering have enabled researchers to develop increasingly specialised synthetic peptides for investigating protein interactions and intracellular molecular signalling. Modern experimental peptide research frequently utilises engineered molecular structures designed to investigate specific interaction pathways under carefully controlled laboratory conditions. FOXO4-DRI forms part of this broader area of peptide research and provides investigators with a defined research compound for experimental molecular and cellular studies. Modern analytical technologies including ultra-high-performance liquid chromatography, FTIR identification and mass spectrometry have significantly improved the ability to verify peptide identity, purity and manufacturing consistency across laboratory-grade research compounds. Today, FOXO4-DRI remains part of the expanding field of investigational peptides utilised exclusively for scientific research and controlled in vitro experimentation.  

Mechanistic Focus in Research

Within controlled laboratory environments, FOXO4-DRI may be investigated in relation to peptide-protein interactions, intracellular signalling and molecular regulatory systems. Research investigations frequently explore:

• Peptide-protein interaction research
• Intracellular molecular signalling
• Cellular communication pathways
• Molecular regulatory mechanisms
• Biochemical pathway analysis
• Protein interaction systems
• Comparative peptide investigations
• Controlled in vitro peptide studies

These experimental models allow researchers to investigate peptide-mediated molecular mechanisms while maintaining carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each batch of FOXO4-DRI supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological quality. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric, microbiological and mass spectrometry techniques. Batch: GF-FOX10-B241

• Assay Content: 12.20 mg
• Purity: 99.7 %
• Identification by FTIR Spectrum: 964
• Identification by Retention Time: 0.996
• Molecular Ion Mass Identification: 5358 Da
• Bacterial Endotoxins: below 0.001 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 12.20 mg with a reported analytical uncertainty of ±0.06 mg. Purity analysis confirmed 99.7 percent purity with a reported analytical uncertainty of ±0.5 percent. Identity was evaluated through FTIR spectrum analysis with a reported result of 964 and retention time analysis with a result of 0.996. Mass spectrometry identified a molecular ion mass of 5358 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin testing returned a result below 0.001 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide independent confirmation of peptide identity, purity, traceability and important batch-specific laboratory quality parameters.  

Research Applications

Within controlled laboratory environments, FOXO4-DRI may be utilised in experimental models designed to investigate peptide-protein interactions, intracellular signalling pathways and molecular regulatory mechanisms. Examples of research applications include:

• Peptide-protein interaction investigations
• Intracellular signalling research
• Molecular pathway analysis
• Cellular communication studies
• Biochemical regulation research
• Protein interaction investigations
• Comparative peptide research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. Each production batch undergoes extensive testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• FTIR spectrum identification
• Endotoxin analysis
• Microbial contamination screening
• Elemental impurity screening
• Complete batch traceability

Independent laboratory testing helps provide researchers with reliable, reproducible and transparently documented research material suitable for advanced scientific investigation.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation. Our analytical verification programme includes assay determination, purity confirmation, FTIR spectrum identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive elemental impurity testing. Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability, independent verification and confidence in the analytical quality of every research compound supplied.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.7 % purity confirmed by COA
• Assay content verified at 12.20 mg
• Identification confirmed by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 5358 Da
• Bacterial endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• Research-grade peptide compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.